{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:12:06Z","timestamp":1786975926166,"version":"build-2736575974"},"publisher-location":"Chichester, UK","reference-count":161,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003044.pub3","type":"reference-entry","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T11:48:19Z","timestamp":1460980099000},"source":"Crossref","is-referenced-by-count":65,"title":["Non-absorbable disaccharides versus placebo\/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis"],"prefix":"10.1002","author":[{"given":"Lise Lotte","family":"Gluud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Vilstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha Y","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,18]]},"reference":[{"key":"10.1002\/14651858.CD003044.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ajg.2012.113","article-title":"Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy","volume":"107","author":"Agrawal","year":"2012","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB2|cit2","doi-asserted-by":"crossref","unstructured":"Agrawal A Sharma P Sharma B Sarin S Secondary prophylaxis of hepatic encephalopathy in cirrhosis: An open label, randomized controlled trial of lactulose, probiotics and no-therapy [abstract] American Journal of Gastroenterology 2010 S105","DOI":"10.14309\/00000434-201010001-00282"},{"key":"10.1002\/14651858.CD003044.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archsurg.1971.01350010027006","article-title":"Lactulose treatment of hepatic encephalopathy in outpatients","volume":"102","author":"Brown","year":"1971","journal-title":"Archives of Surgery"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003044.pub3-BIB4|cit4","first-page":"7","article-title":"Use of pyridoxine-alpha-ketoglutarate (PAK) in hepatic encephalopathy","volume":"2","author":"Corazza","year":"1982","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"10.1002\/14651858.CD003044.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1023\/A:1005556826152","article-title":"Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy","volume":"45","author":"Dhiman","year":"2000","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD003044.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM196908212810803","article-title":"Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial","volume":"281","author":"Elkington","year":"1969","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB7|cit7","first-page":"293","article-title":"Double blind study of lactulose in 18 patients with chronic hepatic encephalopathy after portocaval shunt","volume":"62","author":"Germain","year":"1973","journal-title":"Archives Francaises des Maladies de L'appareil Digestif"},{"key":"10.1002\/14651858.CD003044.pub3-BIB8|cit8","first-page":"225","article-title":"A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portosystemic encephalopathy in cirrhotic patients","volume":"37","author":"Grandi","year":"1991","journal-title":"Minerva Gastroenterologica e Dietologica"},{"key":"10.1002\/14651858.CD003044.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0168-8278(87)80537-8","article-title":"Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial","volume":"4","author":"Heredia","year":"1987","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(88)80513-0","article-title":"Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy","volume":"7","author":"Heredia","year":"1988","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB11|cit11","first-page":"C8","article-title":"Effect of lactulose in cirrhotic patients with portalsystemic shunting and without clinical encephalopathy: A randomized controlled trial [abstract]","volume":"54","author":"Geubel","year":"1991","journal-title":"Acta Gastroenterologica Belgica"},{"key":"10.1002\/14651858.CD003044.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2036.1997.118289000.x","article-title":"Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy","volume":"11","author":"Horsmans","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003044.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/jgh.12160","article-title":"Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy","volume":"28","author":"Jain","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB14|cit14","first-page":"22","article-title":"Lactitol in the treatment of acute hepatic encephalopathy in liver cirrhosis","volume":"15","author":"Jankovic","year":"1996","journal-title":"Archives of Gastroenterohepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB15|cit15","first-page":"13","article-title":"Clinical effect of lactulose in the treatment of subclinical hepatic encephalopathy","volume":"9","author":"Li","year":"1999","journal-title":"Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases"},{"key":"10.1002\/14651858.CD003044.pub3-BIB16|cit16","first-page":"325","article-title":"The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy","volume":"6","author":"McClain","year":"1984","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/MEG.0b013e32834696f5","article-title":"A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy","volume":"23","author":"Mittal","year":"2011","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB18|cit18","unstructured":"Mittal VV Sharma P Sharma B Sarin SK Treatment of minimal hepatic encephalopathy: a randomized controlled trial comparing lactulose, probiotics & L-ornithine L-aspartate with placebo [abstract] Hepatology 2009 471A"},{"key":"10.1002\/14651858.CD003044.pub3-BIB19|cit19","doi-asserted-by":"crossref","unstructured":"Hawley KE Morgan MY A randomised controlled double-blind trial of lactitol and lactulose in acute hepatic encephalopathy in cirrhotic patients [abstract] Journal of Hepatology 1986 86","DOI":"10.1016\/S0168-8278(86)80299-9"},{"key":"10.1002\/14651858.CD003044.pub3-BIB20|cit20","first-page":"1148","article-title":"Lactitol vs lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind randomised trial [abstract]","volume":"6","author":"Hawley","year":"1986","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB21|cit21","first-page":"A1266","article-title":"Randomised controlled double blind trial of lactitol and lactulose in acute hepatic encephalopathy in cirrhotic patients [abstract]","volume":"27","author":"Hawley","year":"1986","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003044.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/hep.1840070617","article-title":"Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial","volume":"7","author":"Morgan","year":"1987","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0168-8278(87)80086-7","article-title":"Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study","volume":"4","author":"Morgan","year":"1987","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0168-8278(89)90009-3","article-title":"Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomized cross-over study","volume":"8","author":"Morgan","year":"1989","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8278(88)80412-4","article-title":"Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy: a randomised cross-over study [abstract]","volume":"7","author":"Stanger","year":"1988","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB26|cit26","first-page":"31","article-title":"Treatment of porto-systemic encephalopathy with lactulose: a randomized controlled study","volume":"55","author":"Pai","year":"1995","journal-title":"Chinese Medical Journal"},{"key":"10.1002\/14651858.CD003044.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","article-title":"Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy","volume":"45","author":"Prasad","year":"2007","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB28|cit28","first-page":"459","article-title":"Does a low-dose of lactulose improve quality of life in patients with liver cirrhosis?","volume-title":"Advances in Hepatic Encephalopathy & Metabolism in Liver Disease: Proceedings of the 9th International Symposium on Ammonia","volume":"64","author":"Quero","year":"1997"},{"key":"10.1002\/14651858.CD003044.pub3-BIB29|cit29","first-page":"A19","article-title":"Does a low-dose of lactulose improve quality of life in patients with liver cirrhosis? [abstract]","volume":"18","author":"Quero","year":"1996","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5144\/0256-4947.2004.374","article-title":"Effect of rectal lactulose administration with oral therapy on time to recovery from hepatic encephalopathy: a randomized study","volume":"24","author":"Raza","year":"2004","journal-title":"Annals of Saudi Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/BF01540265","article-title":"Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt","volume":"34","author":"Riggio","year":"1989","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD003044.pub3-BIB32|cit32","doi-asserted-by":"crossref","unstructured":"Riggio O Balducci G Ariosto F Merli M Romiti A Tremiterra S Lactitol in the treatment of severe chronic hepatic encephalopathy. A randomized cross-over comparison with lactulose [abstract] Journal of Hepatology 1988 168","DOI":"10.1016\/S0168-8278(88)80389-1"},{"key":"10.1002\/14651858.CD003044.pub3-BIB33|cit33","first-page":"524","article-title":"Lactitol in the treatment of chronic hepatic encephalopathy - a randomized cross-over comparison with lactulose","volume":"37","author":"Riggio","year":"1990","journal-title":"Hepato-Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","article-title":"Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study","volume":"42","author":"Riggio","year":"2005","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB35|cit35","first-page":"1510","article-title":"Randomized controlled trial for the prevention of early post-tips hepatic encephalopathy: comparison between rifaximin, lactitol and no treatment [abstract]","volume":"34","author":"Riggio","year":"2001","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB36|cit36","first-page":"459","article-title":"Comparison of results of long-term treatment of chronic hepatic encephalopathy with lactulose and sorbitol","volume":"60","author":"Rodgers","year":"1973","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2009.05.056","article-title":"Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo","volume":"137","author":"Sharma","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1440-1746.2010.06596.x","article-title":"Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose","volume":"26","author":"Sharma","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003044.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1016\/S0168-8278(12)60614-X","article-title":"Primary prophylaxis of hepatic encephalopathy in patients with cirrhosis: an open labelled randomized controlled trial of lactulose versus no lactulose [abstract]","volume":"56","author":"Agrawal","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB40|cit40","unstructured":"Chander SB Praveen S Amit A Kumar SS Primary prophylaxis of hepatic encephalopathy in patients with cirrhosis: A open labelled randomized controlled trial of lactulose versus no lactulose [abstract] Journal of Gastroenterology and Hepatology 2010 A13"},{"key":"10.1002\/14651858.CD003044.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1440-1746.2012.07186.x","article-title":"Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labelled randomized controlled trial of lactulose versus no lactulose","volume":"27","author":"Sharma","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB42|cit42","first-page":"221","article-title":"Lactitol in treatment of subclinical hepatic encephalopathy: a double blind placebo-controlled randomised trial","volume":"17","author":"Shi","year":"1997","journal-title":"Chinese Journal of Digestion"},{"key":"10.1002\/14651858.CD003044.pub3-BIB43|cit43","doi-asserted-by":"crossref","unstructured":"Simmons F Goldstein H Boyle JD A controlled clinical trial of lactulose in hepatic encephalopathy Gastroenterology 1970 827 32 71054874","DOI":"10.1016\/S0016-5085(19)33641-8"},{"key":"10.1002\/14651858.CD003044.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hep.1840070404","article-title":"Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial","volume":"7","author":"Uribe","year":"1987","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB45|cit45","first-page":"765","article-title":"Successful use of lactitol in acute portal systemic encephalopathy. A double blind controlled trial [abstract]","volume":"4","author":"Uribe","year":"1984","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/BF01296659","article-title":"Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial","volume":"32","author":"Uribe","year":"1987","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD003044.pub3-BIB47|cit47","unstructured":"Suzuki H Sato S Suzuki K Muto Y Watanabe A Kuriyama K Phase III study with lactitol (NS-4) for the patients of hyperammonemia: comparative study with lactulose Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1995 1439 73"},{"key":"10.1002\/14651858.CD003044.pub3-BIB49|cit48","first-page":"452A","article-title":"Does lactulose improve psychometric tests and quality of life in cirrhotic patients with subclinical hepatic encephalopathy? [abstract]","volume":"24","author":"Watanabe","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB48|cit49","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.510260606","article-title":"Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy","volume":"26","author":"Watanabe","year":"1997","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000346083","article-title":"Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial","volume":"87","author":"Wen","year":"2013","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD003044.pub3-BIB51|cit51","first-page":"108","article-title":"Research of lactulose in the treatment of minimal hepatic encephalopathy","volume":"11","author":"Xing","year":"2003","journal-title":"World Chinese Journal of Digestion"},{"key":"10.1002\/14651858.CD003044.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ctim.2014.10.005","article-title":"Chinese herbal medicine formula Jieduhuayu granules improves cognitive and neurophysiological functions in patients with cirrhosis who have minimal hepatic encephalopathy: a randomized controlled trial","volume":"22","author":"Yao","year":"2014","journal-title":"Complementary Therapies in Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB53|cit53","first-page":"261","article-title":"Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy","volume":"42","author":"Nie","year":"2003","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1002\/14651858.CD003044.pub3-BIB55|cit54","first-page":"1126","article-title":"Effects of lactulose treatment on the course of subclinical hepatic encephalopathy","volume":"83","author":"Zeng","year":"2003","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1002\/14651858.CD003044.pub3-BIB54|cit55","unstructured":"Zeng Z Li YY Jia L Nie Y-Q Influence of lactulose on the cognitive level and quality of life in patients with minimal hepatic encephalopathy Chinese Journal of Clinical Rehabilitation 2006 165 7"},{"key":"10.1002\/14651858.CD003044.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajg.2013.08.002","article-title":"Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy","volume":"14","author":"Ziada","year":"2013","journal-title":"Arab Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-2036.2010.04257.x","article-title":"Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients","volume":"31","author":"Bajaj","year":"2010","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003044.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(71)90233-6","article-title":"Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature","volume":"51","author":"Bircher","year":"1971","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0002-9610(70)90024-3","article-title":"Encephalopathy after portacaval shunting managed with lactulose","volume":"119","author":"Brown","year":"1970","journal-title":"American Journal of Surgery"},{"key":"10.1002\/14651858.CD003044.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.12.9.702","article-title":"Effect of lactulose on cerebral metabolism in patients with chronic portosystemic encephalopathy","volume":"12","author":"James","year":"1971","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003044.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.26.4.415","article-title":"Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose","volume":"26","author":"Lanthier","year":"1985","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003044.pub3-BIB62|cit62","doi-asserted-by":"crossref","unstructured":"Merli M Caschera M Piat C Pinto G Diofebi M Riggio O The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis Journal of Clinical Gastroenterology 1992 125 7","DOI":"10.1097\/00004836-199209000-00009"},{"key":"10.1002\/14651858.CD003044.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.28.3.255","article-title":"Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy","volume":"28","author":"Patil","year":"1987","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003044.pub3-BIB64|cit64","first-page":"98","article-title":"Effect of lactulose on latent hepatic encephalopathy and plasma ammonia concentration in outpatients with TIPS [abstract]","volume":"25","author":"Piotraschke","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB65|cit65","doi-asserted-by":"crossref","unstructured":"Pockros P Hassanein T Vierling J Heuman D Hillebrand D Chojkier M Phase 2, multicenter, randomized study of AST-120 (spherical carbon adsorbent) vs. lactulose in the treatment of low-grade hepatic encephalopathy (HE) [abstract] Journal of Hepatology 2009 S43","DOI":"10.1016\/S0168-8278(09)60107-0"},{"key":"10.1002\/14651858.CD003044.pub3-BIB66|cit66","first-page":"124A","article-title":"Randomized study of mannitol lavage and of a combination of lactulose and kanamycin in prevention and treatment of posthemorrhagic encephalopathy in patients with cirrhosis [abstract]","volume":"6","author":"Quinton","year":"1982","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1002\/14651858.CD003044.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jamainternmed.2014.4746","article-title":"Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: The HELP Randomized Clinical Trial","volume":"174","author":"Rahimi","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00004836-199008000-00016","article-title":"Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients","volume":"12","author":"Riggio","year":"1990","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0954-6820.1970.tb02954.x","article-title":"Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study","volume":"187","author":"Rorsman","year":"1970","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD003044.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0168-8278(05)80623-3","article-title":"Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy","volume":"21","author":"Salerno","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB71|cit71","first-page":"231","article-title":"Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice","volume":"31","author":"Schomerus","year":"1993","journal-title":"Zeitschrift fur Gastroenterologie"},{"key":"10.1002\/14651858.CD003044.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MEG.0b013e3282f3e6f5","article-title":"An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy","volume":"20","author":"Sharma","year":"2008","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1478-3231.2009.02067.x","article-title":"Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis","volume":"29","author":"Sharma","year":"2009","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD003044.pub3-BIB74|cit74","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MEG.0b013e3283341b7d","article-title":"Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy","volume":"22","author":"Sharma","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0028-3886.63797","article-title":"Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy","volume":"58","author":"Sharma","year":"2010","journal-title":"Neurology India"},{"key":"10.1002\/14651858.CD003044.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/1319-3767.77246","article-title":"Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose","volume":"17","author":"Sharma","year":"2011","journal-title":"Saudi Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB77|cit77","first-page":"299","article-title":"Effects of lactitol on hepatic encephalopathy and plasma amino-acid imbalance","volume":"86","author":"Trovato","year":"1995","journal-title":"Recenti Progressi in Medicina"},{"key":"10.1002\/14651858.CD003044.pub3-BIB78|cit78","first-page":"969","article-title":"Crystalline lactulose in the therapy of hepatic cirrhosis. Evaluation of clinical and immunological parameters. Preliminary results","volume":"42","author":"Vendemiale","year":"1992","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD003044.pub3-BIB79|cit79","first-page":"161","article-title":"Evaluation of rifaximin, placebo and lactulose in reducing the levels of benzodiazepine-like compounds in patients with liver cirrhosis: a pilot study","volume":"31","author":"Venturini","year":"2005","journal-title":"Drugs under Experimental and Clinical Research"},{"key":"10.1002\/14651858.CD003044.pub3-BIB80|cit80","first-page":"245","article-title":"Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy","volume":"39","author":"Zeegen","year":"1970","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB81|cit81","unstructured":"Lactulose for the prevention of hepatic encephalopathy in participants with cirrhosis and upper gastrointestinal haemorrhage Ongoing study 2007"},{"key":"10.1002\/14651858.CD003044.pub3-BIB82|cit82","unstructured":"Impact of lactulose treatment on cognition, assessment of quality of life and changes of intestinal flora in minimal hepatic encephalopathy participants: a multicentre, randomised, open-label and controlled clinical study Ongoing study 2012"},{"key":"10.1002\/14651858.CD003044.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.gastro.2008.07.021","article-title":"Inhibitory control test for the diagnosis of minimal hepatic encephalopathy","volume":"135","author":"Bajaj","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB84|cit84","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/hep.23216","article-title":"Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB85|cit85","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","article-title":"Persistence of cognitive impairment after resolution of overt hepatic encephalopathy","volume":"138","author":"Bajaj","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-2036.2010.04257.x","article-title":"Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients","volume":"31","author":"Bajaj","year":"2010","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003044.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003044.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/ajg.2011.157","article-title":"The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers","volume":"106","author":"Bajaj","year":"2011","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB89|cit89","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11011-012-9303-0","article-title":"A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy","volume":"27","author":"Bajaj","year":"2012","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD003044.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1478-3231.2009.02008.x","article-title":"Radiotracer imaging studies in hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Berding","year":"2009","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD003044.pub3-BIB91|cit91","first-page":"890","article-title":"Treatment of chronic portal-systemic encephalopathy with lactulose","volume":"1","author":"Bircher","year":"1966","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003044.pub3-BIB92|cit92","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/hep.1840150209","article-title":"Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis","volume":"15","author":"Blanc","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB93|cit93","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bmj.38987.492014.94","article-title":"How to formulate research recommendations","volume":"333","author":"Brown","year":"2006","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD003044.pub3-BIB94|cit94","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB95|cit95","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/B978-0-444-62619-6.00034-3","article-title":"Hepatic encephalopathy in alcoholic cirrhosis","volume":"125","author":"Butterworth","year":"2014","journal-title":"Handbook of Clinical Neurology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB96|cit96","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1572-0241.2001.03552.x","article-title":"Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?","volume":"96","author":"Cadranel","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB97|cit97","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/BF01295920","article-title":"Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis","volume":"38","author":"Camma","year":"1993","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD003044.pub3-BIB98|cit98","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1111\/j.1440-1746.1997.tb00512.x","article-title":"Evoked potentials in liver diseases","volume":"12","author":"Chu","year":"1997","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB99|cit99","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial","volume":"72","author":"Conn","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB100|cit100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01320309","article-title":"Survival and prognostic indicators in compensated and decompensated cirrhosis","volume":"31","author":"D'Amico","year":"1986","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD003044.pub3-BIB101|cit101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/0016-5085(92)91188-A","article-title":"Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver","volume":"103","author":"Jongh","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB103|cit103","doi-asserted-by":"crossref","first-page":"e3081","DOI":"10.1371\/journal.pone.0003081","article-title":"Systematic review of the empirical evidence of study publication bias and outcome reporting bias","volume":"3","author":"Dwan","year":"2008","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD003044.pub3-BIB104|cit104","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases","volume":"61","author":"Anonymous","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB105|cit105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB106|cit106","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB107|cit107","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2105\/AJPH.65.12.1304","article-title":"The sickness impact profile. Development of an outcome measure of health care","volume":"65","author":"Gilson","year":"1975","journal-title":"American Journal of Public Health"},{"key":"10.1002\/14651858.CD003044.pub3-BIB108|cit108","unstructured":"Gluud C Nikolova D Klingenberg SL Cochrane Hepato-Biliary Group About Cochrane (Cochrane Review Groups (CRGs)) 2015, Issue 2. Art. No.: LIVER"},{"key":"10.1002\/14651858.CD003044.pub3-BIB109|cit109","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro 2008"},{"key":"10.1002\/14651858.CD003044.pub3-BIB110|cit110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/hep.510280108","article-title":"Subclinical hepatic encephalopathy impairs daily functioning","volume":"28","author":"Groeneweg","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB111|cit111","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3748\/wjg.v12.i19.2969","article-title":"Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy","volume":"12","author":"Grover","year":"2006","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB112|cit112","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1478-3231.2009.02030.x","article-title":"Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Gu\u00e9rit","year":"2009","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD003044.pub3-BIB113|cit113","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0168-8278(00)80110-5","article-title":"Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?","volume":"32","author":"Haussinger","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB115|cit115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1740774508091600","article-title":"Imputation methods for missing outcome data in meta-analysis of clinical trials","volume":"5","author":"Higgins","year":"2008","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD003044.pub3-BIB116|cit116","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003044.pub3-BIB117|cit117","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003044.pub3-BIB118|cit118","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","year":"1997"},{"key":"10.1002\/14651858.CD003044.pub3-BIB119|cit119","first-page":"25","article-title":"Review of the treatment options for chronic constipation","volume":"9","author":"Johanson","year":"2007","journal-title":"MedGenMed: Medscape General Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB120|cit120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2466\/pr0.1963.13.2.503","article-title":"Methods for measuring adjustment and social behavior in the community: i. Rationale, description, discriminative validity and scale development","volume":"13","author":"Katz","year":"1963","journal-title":"Psychological Reports"},{"issue":"3","key":"10.1002\/14651858.CD003044.pub3-BIB121|cit121","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011585","article-title":"Rifaximin for people with hepatic encephalopathy","author":"Kimer","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003044.pub3-BIB122|cit122","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/jhep.2002.30957","article-title":"Critical flicker frequency for quantification of low-grade hepatic encephalopathy","volume":"35","author":"Kircheis","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB123|cit123","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2009.08.003","article-title":"Hepatic encephalopathy and fitness to drive","volume":"137","author":"Kircheis","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB124|cit124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11011-011-9242-1","article-title":"Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease","volume":"26","author":"Lauridsen","year":"2011","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD003044.pub3-BIB125|cit125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/CEG.S58952","article-title":"Efficacy and tolerance of lactitol supplementation for adult constipation: a systematic review and meta-analysis","volume":"7","author":"Miller","year":"2014","journal-title":"Clinical and Experimental Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB126|cit126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/B:MEBR.0000043977.11113.2a","article-title":"Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach","volume":"19","author":"Montagnese","year":"2004","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD003044.pub3-BIB127|cit127","first-page":"556","article-title":"Transformation of lactose to a new disaccharide, lactulose","volume":"69","author":"Montgomery","year":"1929","journal-title":"Science"},{"key":"10.1002\/14651858.CD003044.pub3-BIB128|cit128","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1592\/phco.30.pt2.28S","article-title":"Pharmacoeconomics of hepatic encephalopathy","volume":"30","author":"Neff","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD003044.pub3-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/0140-6736(91)92920-W","article-title":"Regional cerebral blood flow and cognitive function in patients with chronic liver disease","volume":"337","author":"O'Carroll","year":"1991","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD003044.pub3-BIB130|cit130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.MR000035.pub2","article-title":"Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions","author":"Page","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003044.pub3-BIB131|cit131","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(57)90005-3","article-title":"The electroencephalograph in liver disease","volume":"273","author":"Parsons-Smith","year":"1957","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD003044.pub3-BIB132|cit132","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/ajg.2014.264","article-title":"Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization","volume":"109","author":"Patidar","year":"2014","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB133|cit133","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1746-6342.2006.03215.x","article-title":"Review article: the burden of hepatic encephalopathy","volume":"25","author":"Poordad","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7516","key":"10.1002\/14651858.CD003044.pub3-BIB134|cit134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1002\/14651858.CD003044.pub3-BIB135|cit135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1478-3231.2009.02009.x","article-title":"Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Randolph","year":"2009","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD003044.pub3-BIB136|cit136","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD003044.pub3-BIB137|cit137","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00004836-199008000-00016","article-title":"Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients","volume":"12","author":"Riggio","year":"1990","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB138|cit138","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ajg.2010.413","article-title":"Minimal hepatic encephalopathy is associated with falls","volume":"106","author":"Roman","year":"2011","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB139|cit139","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/bmj.282.6260.263","article-title":"A 20-year prospective study of cirrhosis","volume":"282","author":"Saunders","year":"1981","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD003044.pub3-BIB140|cit140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovic","year":"2012","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB141|cit141","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/BF01367675","article-title":"Latent portosystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive","volume":"26","author":"Schomerus","year":"1981","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD003044.pub3-BIB142|cit142","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/A:1020645110880","article-title":"Neuropsychological aspects of portal-systemic encephalopathy","volume":"13","author":"Schomerus","year":"1998","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD003044.pub3-BIB143|cit143","unstructured":"Short Form 36 questionnaire (SF 36) www.sf-36.org (accessed 20 November 2014)"},{"key":"10.1002\/14651858.CD003044.pub3-BIB144|cit144","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/lt.21593","article-title":"Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation","volume":"15","author":"Sotil","year":"2009","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD003044.pub3-BIB145|cit145","unstructured":"Stata Corp, Texas, USA Stata 13 2007"},{"key":"10.1002\/14651858.CD003044.pub3-BIB146|cit146","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cgh.2012.05.016","article-title":"In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB147|cit147","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/lt.21129","article-title":"Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease","volume":"13","author":"Stewart","year":"2007","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD003044.pub3-BIB148|cit148","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02098881","article-title":"Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy","volume":"9","author":"Taylor-Robinson","year":"1994","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD003044.pub3-BIB149|cit149","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness. A practical scale","volume":"2","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003044.pub3-BIB150|cit150","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD003044.pub3-BIB151|cit151","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"key":"10.1002\/14651858.CD003044.pub3-BIB152|cit152","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-196509000-00001","article-title":"The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration","volume":"44","author":"Victor","year":"1965","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB153|cit153","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ajg.2011.314","article-title":"Hospital readmissions among patients with decompensated cirrhosis","volume":"107","author":"Volk","year":"2012","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003044.pub3-BIB154|cit154","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000051415","article-title":"Diagnosis of encephalopathy","volume":"59","author":"Weissenborn","year":"1998","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD003044.pub3-BIB155|cit155","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neuropsychological characterization of hepatic encephalopathy","volume":"34","author":"Weissenborn","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003044.pub3-BIB156|cit156","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","volume":"28","year":"1998","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD003044.pub3-BIB157|cit157","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis","volume":"32","author":"Zipprich","year":"2012","journal-title":"Liver International"},{"issue":"4","key":"10.1002\/14651858.CD003044.pub3-BIB158|cit158","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003044","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy","author":"Als-Nielsen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003044.pub3-BIB159|cit159","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003044.pub2","article-title":"Non-absorbable disaccharides for hepatic encephalopathy","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7447","key":"10.1002\/14651858.CD003044.pub3-BIB160|cit160","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.38048.506134.EE","article-title":"Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials","volume":"328","author":"Als-Nielsen","year":"2004","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD003044.pub3-BIB161|cit161","first-page":"179","article-title":"Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication","volume":"167","author":"Als-Nielsen","year":"2005","journal-title":"Ugeskrift for Laeger"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003044.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003044.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T16:44:54Z","timestamp":1718469894000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003044.pub3"}},"subtitle":[],"editor":[{"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,18]]},"references-count":161,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003044.pub3","relation":{},"subject":[],"published":{"date-parts":[[2016,4,18]]}}}